Introducing PRADA: research priorities set by people affected by MS Learn More →

Accelerating research toward faster diagnoses,
better treatments, and a cure.

Featured

What we still don’t know—and why it matters

Reactions in people with MS are generally mild and short-lived

What we still don’t know—and why it matters

Reactions in people with MS are generally mild and short-lived